MedPath

Oral Immunotherapy for Hen's Egg, Cow's Milk, and Wheat allergic children at outpatient clinic.

Not Applicable
Conditions
food allergy
Registration Number
JPRN-UMIN000013769
Lead Sponsor
ational Hospital Organization Sagamihara National Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The threshold for eliciting positive symptoms is less than or equal to a thirty-second hen's egg, 3ml of cow's milk, or 3g of Udon noodles by oral food challenge test. The subject who is treated by adrenaline injection at oral food challenge test just before this study. The subject who has not-well treated atopic dermatitis, bronchial asthma, or any underlying disease. The subject who is not appropriate for oral immunotherapy, judged by medical doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The purpose of this study is to clarify dose dependent outcome, regarding tolerance acquisition and incidence rate of symptoms by outpatient oral immunotherapy. Patients are enrolled in two groups, which are divided by target amounts of OIT ingestion as 100% or 25% of maximum ingestion amount.
Secondary Outcome Measures
NameTimeMethod
To investigate the efficacy of oral immunotherapy, compared to natural course without the therapy. To confirm the safety of outpatient oral immunotherapy for mild and moderate food allergic children. To analyze the reactivity for oral immunotherapy, stratified by their severity of food allergy. Regarding the OIT patients who haven't reached tolerance at 1 year follow up, they can continue OIT for longer period with their informed consent with its will for participation in advance. The outcome at 2 years' follow up is analyzed in addition to that at 1 year.
© Copyright 2025. All Rights Reserved by MedPath